ANSMフランス供給不足情報(2025年1月3日~2025年1月19日)

IngredientsStatusUpdateSpecialty
Immunoglobulin normal human (IgG)Supply tensionJan. 17, 2025Immunoglobulin normal human IV and SC (based on) –
liraglutideAvailabilityJan. 17, 2025Victoza 6 mg/ml, solution for injection in pre-filled pen –
ondansetronSupply tensionJan. 17, 2025Ondansetron Viatris 2 mg/ml, solution for injection (I.V.) –
valganciclovirRemise à dispositionJan. 17, 2025Rovalcyte 50 mg/ml, powder for oral solution –
tranexamic acidSupply tensionJan. 17, 2025Exacyl 500 mg, film-coated tablet –
etoposideSupply tensionJan. 17, 2025Etoposide Teva, solution for infusion –
furosemideOut of stock16-Jan-25Furosemide Teva 500 mg, scored tablet –
ondansetronOut of stockJan. 16, 2025Zophren 2 mg/ml, solution for injection in ampoule (IV) –
lenalidomideSupply tensionJan. 16, 2025Lenalidomide Mylan, capsule –
levofloxacinSupply tensionJan. 15, 2025Specialties based on Levofloxacin 500 mg scored film-coated tablet –
iomeprolRemise à dispositionJan. 15, 2025Iomeron 300 (300 mg Iodine/mL), solution for injection, 20 ml glass vial –
alfacalcidolAvailabilityJan. 15, 2025Un-Alfa 2 micrograms/1 ml, solution for IV injection in ampoule –
alfacalcidolReleaseJan. 15, 2025Un-Alfa 1 microgram/0.5 ml, solution for IV injection in ampoule –
dexamethasone, neomycin (sulfate of), polymyxin B (sulfate of)ReleaseJan. 15, 2025Maxidrol, ophthalmic ointment –
ciclesonideAvailabilityJan. 15, 2025Alvesco 80 micrograms/dose and 160 micrograms/dose, solution for inhalation in pressurized bottle –
sodium (valproate de)ReleaseJan. 15, 2025Valproate de sodium L.P. 500 mg, comprimé pelliculé sécable à libération prolongée –
amikacine (sulfate d’)Supply tensionJan. 15, 2025Amikacine Viatris 250 mg, 500 mg and 1g, powder for injectable solution in vial –
ondansetronSupply tensionJan. 14, 2025Zophren 4 mg/5 ml, syrup –
pomalidomideOut of stockJan. 14, 2025Pomalidomide Viatris 1, 2, 3 and 4 mg, capsule –
2025年1月20日
このページの先頭へ戻る